Women in Clinical Trials: an FDA Perspective
Authors
Affiliations
Kirubarajan A, Lam A, Yu A, Taheri C, Khan S, Sethuram C J Family Reprod Health. 2021; 15(3):160-171.
PMID: 34721607 PMC: 8536826. DOI: 10.18502/jfrh.v15i3.7133.
Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan).
Eadie A, Brunt K, Herder M Pharmacol Res Perspect. 2021; 9(3):e00794.
PMID: 34087050 PMC: 8177063. DOI: 10.1002/prp2.794.
Insulin sensitivity in critically ill patients: are women more insulin resistant?.
Uyttendaele V, Chase J, Knopp J, Gottlieb R, Shaw G, Desaive T Ann Intensive Care. 2021; 11(1):12.
PMID: 33475909 PMC: 7818291. DOI: 10.1186/s13613-021-00807-7.
Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials.
Gomes M, de la Fuente-Nunez V, Saxena A, Kuesel A Reprod Health. 2018; 14(Suppl 3):172.
PMID: 29297366 PMC: 5751665. DOI: 10.1186/s12978-017-0430-2.
Duneau D, Kondolf H, Im J, Ortiz G, Chow C, Fox M BMC Biol. 2017; 15(1):124.
PMID: 29268741 PMC: 5740927. DOI: 10.1186/s12915-017-0466-3.